Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.78231772 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.78231772 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.78231772 |
4 | modulation by symbiont of host immune response (GO:0052553) | 4.78231772 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.78231772 |
6 | modulation by symbiont of host defense response (GO:0052031) | 4.78231772 |
7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.45383152 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19547629 |
9 | immunoglobulin mediated immune response (GO:0016064) | 3.97606961 |
10 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.76824464 |
11 | negative regulation of interleukin-12 production (GO:0032695) | 3.67914673 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67186332 |
13 | negative regulation of cell killing (GO:0031342) | 3.67186332 |
14 | macrophage activation involved in immune response (GO:0002281) | 3.65274604 |
15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62842883 |
16 | apoptotic cell clearance (GO:0043277) | 3.61284733 |
17 | detection of other organism (GO:0098543) | 3.50764771 |
18 | regulation of mast cell degranulation (GO:0043304) | 3.43383070 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41355188 |
20 | detection of bacterium (GO:0016045) | 3.34151241 |
21 | microglial cell activation (GO:0001774) | 3.27441376 |
22 | positive regulation of mast cell activation (GO:0033005) | 3.26894789 |
23 | regulation of leukocyte degranulation (GO:0043300) | 3.25596193 |
24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22536426 |
25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21894439 |
26 | response to host immune response (GO:0052572) | 3.21894439 |
27 | cellular extravasation (GO:0045123) | 3.19098262 |
28 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19091303 |
29 | granulocyte activation (GO:0036230) | 3.18031483 |
30 | positive regulation of mast cell degranulation (GO:0043306) | 3.17187127 |
31 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17187127 |
32 | mannose metabolic process (GO:0006013) | 3.16857715 |
33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16406591 |
34 | regulation of cholesterol storage (GO:0010885) | 3.11652204 |
35 | detection of external biotic stimulus (GO:0098581) | 3.11454747 |
36 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10925111 |
37 | neutrophil activation (GO:0042119) | 3.09430508 |
38 | neutrophil activation involved in immune response (GO:0002283) | 3.09385077 |
39 | response to host (GO:0075136) | 3.07171065 |
40 | response to host defenses (GO:0052200) | 3.07171065 |
41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07171065 |
42 | positive regulation of interferon-alpha production (GO:0032727) | 3.04287629 |
43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.03446888 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00927740 |
45 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98956145 |
46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98529760 |
47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98131852 |
48 | alpha-linolenic acid metabolic process (GO:0036109) | 2.98048299 |
49 | detection of molecule of bacterial origin (GO:0032490) | 2.95498398 |
50 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.94570779 |
51 | keratan sulfate catabolic process (GO:0042340) | 2.93655736 |
52 | response to thyroid hormone (GO:0097066) | 2.92590324 |
53 | B cell mediated immunity (GO:0019724) | 2.92267292 |
54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91520785 |
55 | amino sugar catabolic process (GO:0046348) | 2.88468037 |
56 | response to muramyl dipeptide (GO:0032495) | 2.88365541 |
57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87341589 |
58 | adhesion of symbiont to host (GO:0044406) | 2.87331143 |
59 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86985033 |
60 | regulation of interferon-alpha production (GO:0032647) | 2.85624697 |
61 | low-density lipoprotein particle clearance (GO:0034383) | 2.85030089 |
62 | glycolipid catabolic process (GO:0019377) | 2.84772076 |
63 | T-helper 1 type immune response (GO:0042088) | 2.83817563 |
64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.83320227 |
65 | protein carboxylation (GO:0018214) | 2.83320227 |
66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81029751 |
67 | pinocytosis (GO:0006907) | 2.79482615 |
68 | virion attachment to host cell (GO:0019062) | 2.79449189 |
69 | adhesion of symbiont to host cell (GO:0044650) | 2.79449189 |
70 | germinal center formation (GO:0002467) | 2.78757823 |
71 | regulation of mast cell activation (GO:0033003) | 2.78054987 |
72 | oligosaccharide catabolic process (GO:0009313) | 2.77142577 |
73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.76613976 |
74 | detection of biotic stimulus (GO:0009595) | 2.74758280 |
75 | regulation of antigen processing and presentation (GO:0002577) | 2.74042939 |
76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71393856 |
77 | cell adhesion mediated by integrin (GO:0033627) | 2.70400045 |
78 | hyaluronan catabolic process (GO:0030214) | 2.68535684 |
79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67142441 |
80 | positive regulation of B cell differentiation (GO:0045579) | 2.66841861 |
81 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66491046 |
82 | macrophage activation (GO:0042116) | 2.64539891 |
83 | plasma lipoprotein particle clearance (GO:0034381) | 2.64511686 |
84 | positive regulation of type 2 immune response (GO:0002830) | 2.60746943 |
85 | regulation of regulated secretory pathway (GO:1903305) | 2.60471613 |
86 | positive regulation of hemostasis (GO:1900048) | 2.58831327 |
87 | positive regulation of blood coagulation (GO:0030194) | 2.58831327 |
88 | regulation of T cell tolerance induction (GO:0002664) | 2.57348754 |
89 | basement membrane organization (GO:0071711) | 2.56235380 |
90 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.54534196 |
91 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54207161 |
92 | regulation of mononuclear cell migration (GO:0071675) | 2.54156109 |
93 | myeloid dendritic cell differentiation (GO:0043011) | 2.54102804 |
94 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.53423562 |
95 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.53258609 |
96 | regulation of tolerance induction (GO:0002643) | 2.53190940 |
97 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52503029 |
98 | response to laminar fluid shear stress (GO:0034616) | 2.52303918 |
99 | positive regulation of coagulation (GO:0050820) | 2.50459750 |
100 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.50035233 |
101 | toxin transport (GO:1901998) | 2.49513206 |
102 | positive regulation of p38MAPK cascade (GO:1900745) | 2.49277951 |
103 | regulation of macrophage cytokine production (GO:0010935) | 2.48799871 |
104 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48020242 |
105 | lysine catabolic process (GO:0006554) | 2.47601300 |
106 | lysine metabolic process (GO:0006553) | 2.47601300 |
107 | response to lipoprotein particle (GO:0055094) | 2.47254098 |
108 | regulation of type 2 immune response (GO:0002828) | 2.46805043 |
109 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45255782 |
110 | cellular response to type I interferon (GO:0071357) | 2.44945467 |
111 | type I interferon signaling pathway (GO:0060337) | 2.44945467 |
112 | ceramide catabolic process (GO:0046514) | 2.44899518 |
113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44112617 |
114 | myeloid dendritic cell activation (GO:0001773) | 2.43432320 |
115 | response to type I interferon (GO:0034340) | 2.42415588 |
116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.42306742 |
117 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.42248020 |
118 | carnitine metabolic process (GO:0009437) | 2.40386855 |
119 | reverse cholesterol transport (GO:0043691) | 2.39751218 |
120 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.39688544 |
121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39329683 |
122 | low-density lipoprotein particle remodeling (GO:0034374) | 2.39005192 |
123 | positive thymic T cell selection (GO:0045059) | 2.38533227 |
124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.37082086 |
125 | negative regulation of lipid storage (GO:0010888) | 2.36671140 |
126 | myeloid leukocyte activation (GO:0002274) | 2.36115975 |
127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.35760689 |
128 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.34895882 |
129 | amyloid precursor protein catabolic process (GO:0042987) | 2.34154376 |
130 | valine metabolic process (GO:0006573) | 2.33815850 |
131 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.33614312 |
132 | complement activation, alternative pathway (GO:0006957) | 2.33187142 |
133 | sulfur amino acid catabolic process (GO:0000098) | 2.33013580 |
134 | phospholipid homeostasis (GO:0055091) | 2.31849550 |
135 | regulation of hypersensitivity (GO:0002883) | 2.30822512 |
136 | I-kappaB phosphorylation (GO:0007252) | 2.30572851 |
137 | protein-lipid complex assembly (GO:0065005) | 2.30570225 |
138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30565005 |
139 | cellular response to interferon-gamma (GO:0071346) | 2.30471692 |
140 | N-acetylneuraminate metabolic process (GO:0006054) | 2.30291346 |
141 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.30113595 |
142 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26596343 |
143 | protein-lipid complex subunit organization (GO:0071825) | 2.26571089 |
144 | ethanol oxidation (GO:0006069) | 2.26330783 |
145 | regulation of complement activation (GO:0030449) | 2.25309634 |
146 | amino-acid betaine metabolic process (GO:0006577) | 2.24588527 |
147 | lipoprotein metabolic process (GO:0042157) | 2.24420995 |
148 | glycosphingolipid catabolic process (GO:0046479) | 2.21411723 |
149 | regulation of protein activation cascade (GO:2000257) | 2.20921858 |
150 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.20767542 |
151 | glyoxylate metabolic process (GO:0046487) | 2.20455239 |
152 | regulation of macrophage chemotaxis (GO:0010758) | 2.20289914 |
153 | regulation of apoptotic cell clearance (GO:2000425) | 2.20038366 |
154 | cysteine metabolic process (GO:0006534) | 2.19291852 |
155 | phagocytosis, engulfment (GO:0006911) | 2.19094348 |
156 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.19044299 |
157 | respiratory burst (GO:0045730) | 2.18798725 |
158 | import into cell (GO:0098657) | 2.18690054 |
159 | lipoprotein transport (GO:0042953) | 2.18650983 |
160 | cholesterol efflux (GO:0033344) | 2.18505344 |
161 | positive regulation of phagocytosis (GO:0050766) | 2.17315898 |
162 | regulation of monocyte chemotaxis (GO:0090025) | 2.17092072 |
163 | plasma lipoprotein particle organization (GO:0071827) | 2.16234420 |
164 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.16041938 |
165 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.15332661 |
166 | L-phenylalanine catabolic process (GO:0006559) | 2.15332661 |
167 | response to peptidoglycan (GO:0032494) | 2.14977328 |
168 | cellular modified amino acid catabolic process (GO:0042219) | 2.14729484 |
169 | regulation of cholesterol homeostasis (GO:2000188) | 2.13977407 |
170 | myeloid cell activation involved in immune response (GO:0002275) | 2.13579757 |
171 | plasma lipoprotein particle remodeling (GO:0034369) | 2.13116110 |
172 | macromolecular complex remodeling (GO:0034367) | 2.13116110 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.13851090 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.56942742 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.46724987 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45195102 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.19681799 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18703889 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94313560 |
8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.90538700 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88274870 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86418865 |
11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.84359573 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80195744 |
13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72773928 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69559473 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60879790 |
16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.55522903 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47192512 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.40007569 |
19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38530169 |
20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31465686 |
21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.21035528 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10837912 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07974202 |
24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04155368 |
25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94804985 |
26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93221305 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93198237 |
28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82690239 |
29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82568468 |
30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75083924 |
31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74154530 |
32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73167496 |
33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71755785 |
34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71611814 |
35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69739703 |
36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68401210 |
37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62854777 |
38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62376881 |
39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62029819 |
40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61385597 |
41 | MAF_26560356_Chip-Seq_TH1_Human | 1.60970868 |
42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.60580343 |
43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58119921 |
44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57598402 |
45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57085188 |
46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56429792 |
47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55072881 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52476729 |
49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51193482 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48751074 |
51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48441319 |
52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48273642 |
53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.47881179 |
54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.47881179 |
55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44238754 |
56 | MYB_26560356_Chip-Seq_TH2_Human | 1.43708853 |
57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43403279 |
58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41555405 |
59 | MYC_22102868_ChIP-Seq_BL_Human | 1.41103029 |
60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38889181 |
61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38875505 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36670176 |
63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34720089 |
64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33047864 |
65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32747532 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30263329 |
67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30032890 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28491931 |
69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28261141 |
70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28028292 |
71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27768427 |
72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27641780 |
73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.27607948 |
74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24140034 |
75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23884140 |
76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23537075 |
77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23439187 |
78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22889328 |
79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22740777 |
80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22066260 |
81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21485817 |
82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21371887 |
83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21129848 |
84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21005037 |
85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20831872 |
86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20630133 |
87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18428104 |
88 | MYB_26560356_Chip-Seq_TH1_Human | 1.17554369 |
89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16320180 |
90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16308358 |
91 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14935467 |
92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14650453 |
93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13618947 |
94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13581068 |
95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12581464 |
96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10377133 |
97 | MAF_26560356_Chip-Seq_TH2_Human | 1.09362642 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09077062 |
99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09022059 |
100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08795647 |
101 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08527138 |
102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07094104 |
103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06298175 |
104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05273677 |
105 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05089830 |
106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04599735 |
107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04566791 |
108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02993757 |
109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00294849 |
110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99964709 |
111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98242407 |
112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97786928 |
113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97515891 |
114 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97302069 |
115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96548257 |
116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96118694 |
117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96027579 |
118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94763715 |
119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94422727 |
120 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94390449 |
121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93961359 |
122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93822860 |
123 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93317577 |
124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93238406 |
125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92794743 |
126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92794743 |
127 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92694478 |
128 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92546057 |
129 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92306403 |
130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91767374 |
131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91299207 |
132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89239812 |
133 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89228403 |
134 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88984658 |
135 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88702471 |
136 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88702471 |
137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88597355 |
138 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88582251 |
139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88492748 |
140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88307120 |
141 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.87928609 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0005058_abnormal_lysosome_morphology | 4.36600704 |
2 | MP0009840_abnormal_foam_cell | 3.28526466 |
3 | MP0008438_abnormal_cutaneous_collagen | 3.14623548 |
4 | MP0003191_abnormal_cellular_cholesterol | 2.86465850 |
5 | * MP0003172_abnormal_lysosome_physiology | 2.50135800 |
6 | MP0005671_abnormal_response_to | 2.40783645 |
7 | MP0003690_abnormal_glial_cell | 2.37378293 |
8 | MP0006082_CNS_inflammation | 2.30481695 |
9 | MP0005360_urolithiasis | 2.26471676 |
10 | MP0003300_gastrointestinal_ulcer | 2.17970139 |
11 | MP0002139_abnormal_hepatobiliary_system | 2.17702293 |
12 | MP0001958_emphysema | 2.08391411 |
13 | MP0003436_decreased_susceptibility_to | 2.05295276 |
14 | MP0001800_abnormal_humoral_immune | 1.99091211 |
15 | MP0003279_aneurysm | 1.93324905 |
16 | MP0002419_abnormal_innate_immunity | 1.93282224 |
17 | MP0003566_abnormal_cell_adhesion | 1.85370398 |
18 | MP0000604_amyloidosis | 1.82551898 |
19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.79264609 |
20 | MP0002420_abnormal_adaptive_immunity | 1.78939670 |
21 | MP0003705_abnormal_hypodermis_morpholog | 1.78624221 |
22 | MP0001819_abnormal_immune_cell | 1.77567247 |
23 | MP0003303_peritoneal_inflammation | 1.72195764 |
24 | MP0000343_altered_response_to | 1.68468667 |
25 | MP0005464_abnormal_platelet_physiology | 1.67610018 |
26 | MP0001533_abnormal_skeleton_physiology | 1.67048459 |
27 | MP0003011_delayed_dark_adaptation | 1.66511717 |
28 | MP0010155_abnormal_intestine_physiology | 1.64952151 |
29 | MP0003075_altered_response_to | 1.63273716 |
30 | MP0009278_abnormal_bone_marrow | 1.61724283 |
31 | MP0003724_increased_susceptibility_to | 1.61413366 |
32 | MP0001835_abnormal_antigen_presentation | 1.61347875 |
33 | MP0005451_abnormal_body_composition | 1.60568505 |
34 | MP0005365_abnormal_bile_salt | 1.60085083 |
35 | MP0004019_abnormal_vitamin_homeostasis | 1.59301768 |
36 | MP0008004_abnormal_stomach_pH | 1.56096398 |
37 | MP0002090_abnormal_vision | 1.54540804 |
38 | MP0002254_reproductive_system_inflammat | 1.54055041 |
39 | MP0010329_abnormal_lipoprotein_level | 1.52037060 |
40 | MP0003828_pulmonary_edema | 1.50246059 |
41 | MP0003252_abnormal_bile_duct | 1.50130104 |
42 | MP0002405_respiratory_system_inflammati | 1.48410007 |
43 | MP0005257_abnormal_intraocular_pressure | 1.47560940 |
44 | MP0002998_abnormal_bone_remodeling | 1.44974978 |
45 | MP0005332_abnormal_amino_acid | 1.42669106 |
46 | MP0001545_abnormal_hematopoietic_system | 1.42402594 |
47 | MP0005397_hematopoietic_system_phenotyp | 1.42402594 |
48 | MP0008260_abnormal_autophagy | 1.42336267 |
49 | MP0003186_abnormal_redox_activity | 1.41996219 |
50 | MP0006054_spinal_hemorrhage | 1.39668246 |
51 | MP0009643_abnormal_urine_homeostasis | 1.38706599 |
52 | MP0003195_calcinosis | 1.36543509 |
53 | MP0005670_abnormal_white_adipose | 1.35925044 |
54 | MP0009764_decreased_sensitivity_to | 1.33849542 |
55 | MP0009333_abnormal_splenocyte_physiolog | 1.33325325 |
56 | MP0002877_abnormal_melanocyte_morpholog | 1.31922787 |
57 | MP0000716_abnormal_immune_system | 1.30137858 |
58 | MP0005167_abnormal_blood-brain_barrier | 1.27996037 |
59 | MP0009384_cardiac_valve_regurgitation | 1.27170369 |
60 | MP0003329_amyloid_beta_deposits | 1.27076748 |
61 | MP0002148_abnormal_hypersensitivity_rea | 1.26620335 |
62 | MP0005275_abnormal_skin_tensile | 1.26197539 |
63 | MP0003656_abnormal_erythrocyte_physiolo | 1.24487018 |
64 | MP0005083_abnormal_biliary_tract | 1.21566457 |
65 | MP0010368_abnormal_lymphatic_system | 1.21237932 |
66 | MP0002398_abnormal_bone_marrow | 1.21012838 |
67 | MP0008469_abnormal_protein_level | 1.20645607 |
68 | MP0005000_abnormal_immune_tolerance | 1.19980107 |
69 | MP0005025_abnormal_response_to | 1.19844267 |
70 | MP0004272_abnormal_basement_membrane | 1.18299248 |
71 | MP0004947_skin_inflammation | 1.18241879 |
72 | MP0002295_abnormal_pulmonary_circulatio | 1.17575843 |
73 | MP0005164_abnormal_response_to | 1.17339197 |
74 | MP0005387_immune_system_phenotype | 1.16795603 |
75 | MP0001790_abnormal_immune_system | 1.16795603 |
76 | MP0005023_abnormal_wound_healing | 1.15650295 |
77 | MP0003950_abnormal_plasma_membrane | 1.15207907 |
78 | MP0005085_abnormal_gallbladder_physiolo | 1.14525999 |
79 | MP0002136_abnormal_kidney_physiology | 1.12541123 |
80 | MP0005166_decreased_susceptibility_to | 1.11086779 |
81 | MP0009785_altered_susceptibility_to | 1.09324345 |
82 | MP0002452_abnormal_antigen_presenting | 1.07861714 |
83 | * MP0000920_abnormal_myelination | 1.07582925 |
84 | MP0002118_abnormal_lipid_homeostasis | 1.07344711 |
85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05900156 |
86 | MP0003448_altered_tumor_morphology | 1.05842649 |
87 | MP0000689_abnormal_spleen_morphology | 1.04835791 |
88 | MP0002429_abnormal_blood_cell | 1.04319136 |
89 | MP0000609_abnormal_liver_physiology | 1.03584726 |
90 | MP0001853_heart_inflammation | 1.02379407 |
91 | MP0001756_abnormal_urination | 1.01945462 |
92 | MP0001845_abnormal_inflammatory_respons | 1.01692626 |
93 | MP0002933_joint_inflammation | 1.00629235 |
94 | MP0005319_abnormal_enzyme/_coenzyme | 1.00472119 |
95 | MP0002138_abnormal_hepatobiliary_system | 1.00212102 |
96 | MP0005390_skeleton_phenotype | 0.98978962 |
97 | MP0004130_abnormal_muscle_cell | 0.97433027 |
98 | MP0002722_abnormal_immune_system | 0.96515823 |
99 | MP0000858_altered_metastatic_potential | 0.96494560 |
100 | MP0005310_abnormal_salivary_gland | 0.95790247 |
101 | MP0003763_abnormal_thymus_physiology | 0.95108271 |
102 | MP0000465_gastrointestinal_hemorrhage | 0.94468376 |
103 | MP0004782_abnormal_surfactant_physiolog | 0.93072992 |
104 | MP0000767_abnormal_smooth_muscle | 0.91890847 |
105 | MP0000569_abnormal_digit_pigmentation | 0.91649000 |
106 | MP0005165_increased_susceptibility_to | 0.91372165 |
107 | MP0003183_abnormal_peptide_metabolism | 0.91316383 |
108 | MP0002168_other_aberrant_phenotype | 0.91157686 |
109 | MP0001915_intracranial_hemorrhage | 0.90643164 |
110 | MP0003091_abnormal_cell_migration | 0.90085133 |
111 | MP0004510_myositis | 0.89298450 |
112 | MP0000249_abnormal_blood_vessel | 0.89032384 |
113 | MP0000685_abnormal_immune_system | 0.88186929 |
114 | MP0003453_abnormal_keratinocyte_physiol | 0.87649133 |
115 | MP0003866_abnormal_defecation | 0.86577237 |
116 | MP0009763_increased_sensitivity_to | 0.86234317 |
117 | MP0003045_fibrosis | 0.86164123 |
118 | MP0003806_abnormal_nucleotide_metabolis | 0.84626452 |
119 | MP0001879_abnormal_lymphatic_vessel | 0.84507167 |
120 | MP0001542_abnormal_bone_strength | 0.84493238 |
121 | MP0004883_abnormal_blood_vessel | 0.83361481 |
122 | MP0001851_eye_inflammation | 0.83140070 |
123 | MP0002723_abnormal_immune_serum | 0.82735086 |
124 | MP0003795_abnormal_bone_structure | 0.81830706 |
125 | MP0002135_abnormal_kidney_morphology | 0.81436784 |
126 | MP0000015_abnormal_ear_pigmentation | 0.76502216 |
127 | MP0002166_altered_tumor_susceptibility | 0.74722268 |
128 | MP0005409_darkened_coat_color | 0.72089270 |
129 | MP0001663_abnormal_digestive_system | 0.70607216 |
130 | MP0008874_decreased_physiological_sensi | 0.69610481 |
131 | MP0004808_abnormal_hematopoietic_stem | 0.67117537 |
132 | MP0002132_abnormal_respiratory_system | 0.64242819 |
133 | MP0000371_diluted_coat_color | 0.59817777 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 5.44667354 |
2 | * Increased cerebral lipofuscin (HP:0011813) | 5.32097825 |
3 | Dysostosis multiplex (HP:0000943) | 5.04821972 |
4 | Systemic lupus erythematosus (HP:0002725) | 4.78216579 |
5 | * Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.58098905 |
6 | Mucopolysacchariduria (HP:0008155) | 4.30916440 |
7 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.30916440 |
8 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.10835418 |
9 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.10835418 |
10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.10835418 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.95404669 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.95404669 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.95404669 |
14 | Axonal loss (HP:0003447) | 3.64310577 |
15 | Abnormality of macrophages (HP:0004311) | 3.60500154 |
16 | Complement deficiency (HP:0004431) | 3.46319498 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.42741183 |
18 | Recurrent abscess formation (HP:0002722) | 3.40631399 |
19 | Glomerulonephritis (HP:0000099) | 3.38466460 |
20 | Myositis (HP:0100614) | 3.32244599 |
21 | Loss of speech (HP:0002371) | 3.19317083 |
22 | Recurrent bacterial skin infections (HP:0005406) | 3.17422354 |
23 | Prolonged bleeding time (HP:0003010) | 3.12987784 |
24 | Eczematoid dermatitis (HP:0000976) | 3.10905910 |
25 | Orchitis (HP:0100796) | 3.06716749 |
26 | Epistaxis (HP:0000421) | 3.02884374 |
27 | Xanthomatosis (HP:0000991) | 2.96185669 |
28 | Myocardial infarction (HP:0001658) | 2.94522393 |
29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84015759 |
30 | Interstitial pulmonary disease (HP:0006530) | 2.82493961 |
31 | Premature rupture of membranes (HP:0001788) | 2.81412794 |
32 | Neurofibrillary tangles (HP:0002185) | 2.80854957 |
33 | Obstructive lung disease (HP:0006536) | 2.80065966 |
34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.80065966 |
35 | Abnormality of complement system (HP:0005339) | 2.77628547 |
36 | Retrobulbar optic neuritis (HP:0100654) | 2.74741983 |
37 | Optic neuritis (HP:0100653) | 2.74741983 |
38 | Cervical subluxation (HP:0003308) | 2.70989874 |
39 | Stomatitis (HP:0010280) | 2.70268437 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.63701557 |
41 | Spondylolisthesis (HP:0003302) | 2.62245011 |
42 | * Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.60461565 |
43 | Mediastinal lymphadenopathy (HP:0100721) | 2.58435722 |
44 | Mutism (HP:0002300) | 2.52891771 |
45 | Nephritis (HP:0000123) | 2.46561917 |
46 | Retinal atrophy (HP:0001105) | 2.45000358 |
47 | Asymmetric septal hypertrophy (HP:0001670) | 2.43736157 |
48 | Cerebral aneurysm (HP:0004944) | 2.42256961 |
49 | Tetraparesis (HP:0002273) | 2.41793806 |
50 | Pulmonary infiltrates (HP:0002113) | 2.41530238 |
51 | Ovoid vertebral bodies (HP:0003300) | 2.40344658 |
52 | Vasculitis (HP:0002633) | 2.38872796 |
53 | Meningitis (HP:0001287) | 2.37695662 |
54 | Hyperlipoproteinemia (HP:0010980) | 2.35878838 |
55 | Protrusio acetabuli (HP:0003179) | 2.33289943 |
56 | Deep venous thrombosis (HP:0002625) | 2.32440209 |
57 | Aortic aneurysm (HP:0004942) | 2.32128391 |
58 | Vertebral compression fractures (HP:0002953) | 2.31085182 |
59 | Hydroxyprolinuria (HP:0003080) | 2.27224571 |
60 | Abnormality of proline metabolism (HP:0010907) | 2.27224571 |
61 | Abnormality of the lumbar spine (HP:0100712) | 2.26713313 |
62 | Joint hemorrhage (HP:0005261) | 2.26425912 |
63 | Vascular calcification (HP:0004934) | 2.25606588 |
64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25458919 |
65 | Recurrent fungal infections (HP:0002841) | 2.25366623 |
66 | Nuclear cataract (HP:0100018) | 2.24483130 |
67 | Pathologic fracture (HP:0002756) | 2.23420147 |
68 | Aortic dissection (HP:0002647) | 2.22561679 |
69 | Arterial tortuosity (HP:0005116) | 2.21884234 |
70 | Cardiovascular calcification (HP:0011915) | 2.21338049 |
71 | Vascular tortuosity (HP:0004948) | 2.21138404 |
72 | Purpura (HP:0000979) | 2.20375155 |
73 | Mitral stenosis (HP:0001718) | 2.17034878 |
74 | Polycythemia (HP:0001901) | 2.13915641 |
75 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.13271169 |
76 | Menorrhagia (HP:0000132) | 2.09931667 |
77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09921402 |
78 | Osteolytic defects of the hand bones (HP:0009699) | 2.09921402 |
79 | Cellulitis (HP:0100658) | 2.09056334 |
80 | Hemoptysis (HP:0002105) | 2.08821180 |
81 | Thoracic kyphosis (HP:0002942) | 2.08761319 |
82 | Hepatosplenomegaly (HP:0001433) | 2.08710585 |
83 | Gastrointestinal infarctions (HP:0005244) | 2.06937208 |
84 | Hypercholesterolemia (HP:0003124) | 2.06516320 |
85 | Increased IgE level (HP:0003212) | 2.05752700 |
86 | Pulmonary embolism (HP:0002204) | 2.04801876 |
87 | Diminished motivation (HP:0000745) | 2.04151925 |
88 | Abnormality of iron homeostasis (HP:0011031) | 2.04117271 |
89 | Chest pain (HP:0100749) | 2.03844828 |
90 | Arterial thrombosis (HP:0004420) | 2.03023803 |
91 | Apathy (HP:0000741) | 2.02557349 |
92 | Hypoalphalipoproteinemia (HP:0003233) | 2.00042785 |
93 | Cerebral inclusion bodies (HP:0100314) | 1.99995112 |
94 | Gingival bleeding (HP:0000225) | 1.99917111 |
95 | Amyloidosis (HP:0011034) | 1.99772479 |
96 | Esophageal varix (HP:0002040) | 1.98971465 |
97 | Disinhibition (HP:0000734) | 1.98584131 |
98 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98092585 |
99 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98092585 |
100 | Supranuclear gaze palsy (HP:0000605) | 1.97644956 |
101 | Abnormal platelet volume (HP:0011876) | 1.96977292 |
102 | Peritonitis (HP:0002586) | 1.96968740 |
103 | Keratoconjunctivitis sicca (HP:0001097) | 1.95744772 |
104 | Recurrent viral infections (HP:0004429) | 1.95165666 |
105 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93987611 |
106 | Protuberant abdomen (HP:0001538) | 1.93858848 |
107 | Beaking of vertebral bodies (HP:0004568) | 1.93843964 |
108 | Petechiae (HP:0000967) | 1.91651249 |
109 | * Progressive visual loss (HP:0000529) | 1.89930388 |
110 | Recurrent skin infections (HP:0001581) | 1.89832534 |
111 | Encephalitis (HP:0002383) | 1.89670755 |
112 | Gingivitis (HP:0000230) | 1.89420066 |
113 | Episodic fever (HP:0001954) | 1.89231317 |
114 | Prolonged neonatal jaundice (HP:0006579) | 1.87878427 |
115 | Broad metatarsal (HP:0001783) | 1.87554521 |
116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87538344 |
117 | Restrictive lung disease (HP:0002091) | 1.87298760 |
118 | Increased CSF protein (HP:0002922) | 1.86715788 |
119 | Nausea (HP:0002018) | 1.85727945 |
120 | Osteomyelitis (HP:0002754) | 1.83235781 |
121 | Progressive neurologic deterioration (HP:0002344) | 1.81301043 |
122 | Hypergammaglobulinemia (HP:0010702) | 1.80904074 |
123 | Sensorimotor neuropathy (HP:0007141) | 1.80554948 |
124 | Pustule (HP:0200039) | 1.80304265 |
125 | Neuronal loss in central nervous system (HP:0002529) | 1.79282500 |
126 | Disproportionate tall stature (HP:0001519) | 1.78724641 |
127 | Urticaria (HP:0001025) | 1.77557260 |
128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.77507205 |
129 | Thrombocytosis (HP:0001894) | 1.76918583 |
130 | Inflammation of the large intestine (HP:0002037) | 1.76013567 |
131 | J-shaped sella turcica (HP:0002680) | 1.75894797 |
132 | Peripheral demyelination (HP:0011096) | 1.73737773 |
133 | Hematochezia (HP:0002573) | 1.73522922 |
134 | Conjunctival telangiectasia (HP:0000524) | 1.73125830 |
135 | Bone pain (HP:0002653) | 1.72845882 |
136 | Increased serum ferritin (HP:0003281) | 1.71084063 |
137 | Nonimmune hydrops fetalis (HP:0001790) | 1.70924488 |
138 | Spontaneous hematomas (HP:0007420) | 1.67377723 |
139 | Blue sclerae (HP:0000592) | 1.66455175 |
140 | Skin nodule (HP:0200036) | 1.66269309 |
141 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.65796305 |
142 | Joint stiffness (HP:0001387) | 1.65401247 |
143 | Abnormal platelet function (HP:0011869) | 1.64961132 |
144 | Impaired platelet aggregation (HP:0003540) | 1.64961132 |
145 | Global brain atrophy (HP:0002283) | 1.64590508 |
146 | Intrahepatic cholestasis (HP:0001406) | 1.63411309 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.03827318 |
2 | TGFBR2 | 3.41488734 |
3 | TRIB3 | 3.15078608 |
4 | SIK1 | 3.05948695 |
5 | PRPF4B | 2.75293746 |
6 | EPHB1 | 2.60162945 |
7 | TAOK3 | 2.51963858 |
8 | CAMK1D | 2.25505855 |
9 | TYK2 | 2.22262176 |
10 | KIT | 2.20650960 |
11 | TBK1 | 2.09671994 |
12 | RIPK1 | 2.02223564 |
13 | NEK9 | 1.95734062 |
14 | BLK | 1.93835912 |
15 | IRAK3 | 1.88605642 |
16 | MAP2K3 | 1.80634172 |
17 | JAK1 | 1.71751856 |
18 | CAMK1G | 1.70203353 |
19 | PTK6 | 1.68487582 |
20 | LRRK2 | 1.67313369 |
21 | BMPR2 | 1.60992979 |
22 | MAP3K14 | 1.54501683 |
23 | PAK4 | 1.52049640 |
24 | TTN | 1.51322458 |
25 | TAOK2 | 1.49273840 |
26 | PKN2 | 1.44770799 |
27 | FGFR4 | 1.43637158 |
28 | FGR | 1.43169651 |
29 | TESK2 | 1.40930193 |
30 | STK10 | 1.37325488 |
31 | TXK | 1.34776777 |
32 | IRAK4 | 1.34388282 |
33 | MAP3K11 | 1.34380241 |
34 | GRK7 | 1.32233194 |
35 | MAP4K1 | 1.29683200 |
36 | CDC42BPA | 1.26471847 |
37 | PIM2 | 1.24956480 |
38 | MAP3K1 | 1.21269820 |
39 | KDR | 1.18112247 |
40 | CSF1R | 1.16357779 |
41 | TNK2 | 1.15364592 |
42 | MAP3K3 | 1.13834937 |
43 | BMX | 1.13509302 |
44 | MST1R | 1.12986078 |
45 | PBK | 1.10960676 |
46 | BCKDK | 1.08211762 |
47 | CSK | 1.07994467 |
48 | TRPM7 | 1.07545859 |
49 | TAOK1 | 1.04705724 |
50 | ZAP70 | 1.03425659 |
51 | DDR2 | 1.03396837 |
52 | CDK6 | 1.02700304 |
53 | NME2 | 1.01328662 |
54 | GRK6 | 1.00479247 |
55 | JAK2 | 0.98391135 |
56 | PTK2 | 0.91907078 |
57 | IKBKB | 0.91319383 |
58 | JAK3 | 0.91225409 |
59 | TESK1 | 0.90457146 |
60 | HCK | 0.90299485 |
61 | IKBKE | 0.89710118 |
62 | ITK | 0.88880649 |
63 | BTK | 0.84890274 |
64 | PDK1 | 0.84650871 |
65 | MAP3K13 | 0.84281743 |
66 | RPS6KA4 | 0.82721161 |
67 | MAPK12 | 0.78013176 |
68 | KSR2 | 0.77949460 |
69 | MET | 0.77862654 |
70 | PIK3CG | 0.77026813 |
71 | HIPK2 | 0.76367805 |
72 | SGK3 | 0.75808620 |
73 | TIE1 | 0.73612907 |
74 | PDGFRA | 0.72662533 |
75 | LYN | 0.72252558 |
76 | IRAK2 | 0.70848559 |
77 | EGFR | 0.70484954 |
78 | WNK4 | 0.69447525 |
79 | ABL2 | 0.69270380 |
80 | EPHA3 | 0.68971891 |
81 | MARK3 | 0.67614344 |
82 | DYRK1B | 0.66364317 |
83 | PAK2 | 0.66176586 |
84 | ICK | 0.65728080 |
85 | SCYL2 | 0.64395861 |
86 | ARAF | 0.64293487 |
87 | RIPK4 | 0.64036772 |
88 | MARK2 | 0.62830403 |
89 | PRKD2 | 0.61877566 |
90 | IGF1R | 0.61409492 |
91 | MAP3K2 | 0.60935330 |
92 | DMPK | 0.60548305 |
93 | SIK3 | 0.59084369 |
94 | LCK | 0.57895005 |
95 | SIK2 | 0.57690683 |
96 | FGFR3 | 0.56849625 |
97 | CHUK | 0.55980551 |
98 | FES | 0.55254028 |
99 | GSK3A | 0.55062015 |
100 | ABL1 | 0.54865119 |
101 | MATK | 0.53955053 |
102 | YES1 | 0.53759967 |
103 | MAPK7 | 0.53571741 |
104 | GRK1 | 0.52569712 |
105 | MAP3K7 | 0.52510139 |
106 | SRC | 0.52298720 |
107 | PRKCD | 0.52203047 |
108 | OXSR1 | 0.51543250 |
109 | PDGFRB | 0.51355368 |
110 | PRKAA2 | 0.49797387 |
111 | TEC | 0.49782973 |
112 | EPHB2 | 0.49274068 |
113 | SYK | 0.47773952 |
114 | DAPK2 | 0.47644555 |
115 | PTK2B | 0.47233670 |
116 | PRKG2 | 0.46662525 |
117 | CDK12 | 0.46496684 |
118 | IRAK1 | 0.45635968 |
119 | MOS | 0.44828988 |
120 | CAMKK2 | 0.44662970 |
121 | RPS6KA2 | 0.44580809 |
122 | PDPK1 | 0.44389265 |
123 | RPS6KC1 | 0.43206041 |
124 | RPS6KL1 | 0.43206041 |
125 | MAP3K5 | 0.42631137 |
126 | MYLK | 0.42625711 |
127 | MAPKAPK2 | 0.42491722 |
128 | FYN | 0.41918645 |
129 | PRKCH | 0.41757809 |
130 | MST4 | 0.40923360 |
131 | MAP2K6 | 0.40839110 |
132 | MAPK11 | 0.40654647 |
133 | PRKD1 | 0.39739278 |
134 | FGFR1 | 0.38929186 |
135 | MAP3K6 | 0.38736051 |
136 | RET | 0.37460385 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.37198360 |
2 | * Lysosome_Homo sapiens_hsa04142 | 3.36535924 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.21664796 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.08239016 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.83295585 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.50966452 |
7 | Asthma_Homo sapiens_hsa05310 | 2.49634791 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.36830529 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36320104 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22333498 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.95787113 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90856077 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89961820 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79863846 |
15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65390751 |
16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64807130 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61390956 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.61257133 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58417608 |
20 | Malaria_Homo sapiens_hsa05144 | 1.57300176 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53997777 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49507410 |
23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48982125 |
24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44304335 |
25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43086994 |
26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40989100 |
27 | Peroxisome_Homo sapiens_hsa04146 | 1.36853505 |
28 | Phagosome_Homo sapiens_hsa04145 | 1.36743092 |
29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33304616 |
30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28928732 |
31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28690103 |
32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27868409 |
33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27020426 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26394511 |
35 | Influenza A_Homo sapiens_hsa05164 | 1.26025363 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23937507 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.19536307 |
38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14960257 |
39 | Pertussis_Homo sapiens_hsa05133 | 1.12813564 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12248378 |
41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10725726 |
42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08161911 |
43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07007061 |
44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06575855 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.06050458 |
46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04148731 |
47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03554071 |
48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02774743 |
49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02243457 |
50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99638054 |
51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97238643 |
52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96658109 |
53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96638294 |
54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96385708 |
55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93743834 |
56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92853555 |
57 | ABC transporters_Homo sapiens_hsa02010 | 0.92135831 |
58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91408310 |
59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91080751 |
60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90729607 |
61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88780786 |
62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88379681 |
63 | Legionellosis_Homo sapiens_hsa05134 | 0.88004615 |
64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85904853 |
65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85246701 |
66 | Shigellosis_Homo sapiens_hsa05131 | 0.83772460 |
67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83066334 |
68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82866365 |
69 | Amoebiasis_Homo sapiens_hsa05146 | 0.82446730 |
70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81942264 |
71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80472588 |
72 | Mineral absorption_Homo sapiens_hsa04978 | 0.78944067 |
73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78487553 |
74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75139633 |
75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74601081 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 0.74312167 |
77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74030970 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73066435 |
79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73064311 |
80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72301313 |
81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71133383 |
82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69069081 |
83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68129336 |
84 | Lysine degradation_Homo sapiens_hsa00310 | 0.67000868 |
85 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66734634 |
86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66503442 |
87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66288192 |
88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65123207 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65035644 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62100083 |
91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61893996 |
92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61748581 |
93 | Prion diseases_Homo sapiens_hsa05020 | 0.61171255 |
94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60647490 |
95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60474664 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.60341818 |
97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59894371 |
98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59552235 |
99 | Focal adhesion_Homo sapiens_hsa04510 | 0.58749667 |
100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58468892 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58286216 |
102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57969868 |
103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57935238 |
104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57392703 |
105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57129404 |
106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56985781 |
107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55969572 |
108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55437035 |
109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55369380 |
110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54702646 |
111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54159180 |
112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52507131 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52196483 |
114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51746819 |
115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51705664 |
116 | Apoptosis_Homo sapiens_hsa04210 | 0.51649439 |
117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50559795 |
118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50295412 |
119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49321980 |
120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49210794 |
121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48727806 |
122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48520623 |
123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48339776 |
124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48171564 |
125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47683080 |
126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47665417 |
127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46846833 |
128 | Insulin resistance_Homo sapiens_hsa04931 | 0.46813881 |
129 | Salmonella infection_Homo sapiens_hsa05132 | 0.46447413 |
130 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45097739 |
131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44387069 |
132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44111103 |
133 | Measles_Homo sapiens_hsa05162 | 0.43926552 |
134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43916053 |
135 | Hepatitis C_Homo sapiens_hsa05160 | 0.43420568 |
136 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42903694 |
137 | Platelet activation_Homo sapiens_hsa04611 | 0.42138283 |
138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40782477 |
139 | Endocytosis_Homo sapiens_hsa04144 | 0.40739421 |
140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39978936 |
141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38559379 |
142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38330040 |
143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32808708 |
144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32485706 |
145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29826492 |
146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28491624 |
147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28121406 |
148 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27482697 |
149 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27428230 |
150 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26941313 |